|
MGC16142 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.63720000001533E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.04219999999844E-05 |
| Normal-vs-Stage2 |
1.289360E-01 |
| Normal-vs-Stage3 |
3.803200E-01 |
| Normal-vs-Stage4 |
1.394200E-01 |
| Stage1-vs-Stage2 |
5.050400E-01 |
| Stage1-vs-Stage3 |
6.302400E-02 |
| Stage1-vs-Stage4 |
2.006800E-01 |
| Stage2-vs-Stage3 |
2.055000E-01 |
| Stage2-vs-Stage4 |
2.875600E-01 |
| Stage3-vs-Stage4 |
6.437800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.54899999999159E-06 |
| Normal-vs-AfricanAmerican |
1.010450E-02 |
| Normal-vs-Asian |
7.464500E-02 |
| Caucasian-vs-AfricanAmerican |
6.471400E-01 |
| Caucasian-vs-Asian |
8.332200E-01 |
| AfricanAmerican-vs-Asian |
7.939200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.37710000003288E-06 |
| Normal-vs-Female |
7.619700E-03 |
| Male-vs-Female |
9.933600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.115900E-02 |
| Normal-vs-Extreme_Weight |
1.822390E-04 |
| Normal-vs-Obese |
4.102500E-03 |
| Normal-vs-Extreme_Obese |
5.185600E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.743200E-01 |
| Normal_Weight-vs-Obese |
1.850770E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.884400E-01 |
| Extreme_Weight-vs-Obese |
5.478400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.916610E-01 |
| Obese-vs-Extreme_Obese |
8.400300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.358220E-02 |
| Normal-vs-Age(41-60Yrs) |
3.81700000051666E-07 |
| Normal-vs-Age(61-80Yrs) |
7.412600E-04 |
| Normal-vs-Age(81-100Yrs) |
4.406600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.799000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.550800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.582800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.672030E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.457600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.521600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.82220041675419E-10 |
| Normal-VS-Type2 PRCC |
9.729400E-01 |
| Normal-VS-KIRP CIMP |
4.170000E-01 |
| Normal-VS-Unclassified PRCC |
1.138220E-02 |
| Type1 PRCC-VS-Type2 PRCC |
6.3552052509408E-11 |
| Type1 PRCC-VS-KIRP CIMP |
8.32570000000032E-05 |
| Type1 PRCC-VS-Unclassified PRCC |
1.160380E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.977400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.111640E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.118340E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.701700E-02 |
| Normal-vs-N1 |
3.417600E-02 |
| Normal-vs-N2 |
4.756000E-01 |
| N0-vs-N1 |
6.065600E-01 |
| N0-vs-N2 |
2.880000E-01 |
| N1-vs-N2 |
1.436820E-01 |
|
|
